Oldham Mark A, Pigeon Wilfred R, Yurcheshen Michael, Hisamoto Kazuhiro, Knight Peter A, Lee Hochang B
Department of Psychiatry, University of Rochester Medical Center, Rochester, NY, USA.
Center of Excellence for Suicide Prevention, U.S. Department of Veterans Affairs, Canandaigua, NY, USA.
Sleep Adv. 2024 May 30;5(1):zpae034. doi: 10.1093/sleepadvances/zpae034. eCollection 2024.
A high prevalence of sleep apnea has been reported among transcatheter aortic valve replacement (AVR) patients; however, the prevalence of sleep apnea in the younger and relatively healthier population of surgical AVR (SAVR) patients is unknown.
We assessed the prevalence of sleep apnea and overall sleep quality in patients having SAVR. Participants aged 50-89 were eligible for recruitment. All participants completed type II HST before SAVR. Sleep apnea was defined as an apnea-hypopnea index (AHI) ≥ 5 events/hour. The current use of positive airway pressure was exclusionary.
The 46 participants (32 males/14 females) had a mean age of 66.6 years, body mass index of 30, AHI of 23.5, and obstructive AHI of 22.0. Only four participants had a prior sleep apnea diagnosis, yet all but one had sleep apnea on type II sleep testing. Two-thirds of sleep apnea was moderate or severe (AHI ≥ 15). A quarter of respiratory events were defined by arousals without desaturations. Whereas most sleep parameters resembled those of similarly aged community cohorts, mean percentage of N3 was reduced, accounting for only 3.8% of total sleep time.
Type II home sleep testing (HST) revealed a 97.8% prevalence of sleep apnea in this sample, most of which was undiagnosed obstructive sleep apnea. Roughly two-thirds of sleep apnea was moderate or severe. Such a high impact of obstructive sleep apnea among patients with severe aortic valve disease deserves further investigation on potential underlying mechanisms and clinical implications.
经导管主动脉瓣置换术(AVR)患者中睡眠呼吸暂停的患病率较高;然而,在年龄较小且相对健康的外科主动脉瓣置换术(SAVR)患者人群中,睡眠呼吸暂停的患病率尚不清楚。
我们评估了接受SAVR患者的睡眠呼吸暂停患病率和总体睡眠质量。年龄在50 - 89岁的参与者符合招募条件。所有参与者在SAVR前完成II型家庭睡眠测试(HST)。睡眠呼吸暂停定义为呼吸暂停低通气指数(AHI)≥5次/小时。当前使用气道正压通气者被排除。
46名参与者(32名男性/14名女性)的平均年龄为66.6岁,体重指数为30,AHI为23.5,阻塞性AHI为22.0。只有4名参与者先前被诊断为睡眠呼吸暂停,但除1人外,其余所有人在II型睡眠测试中都存在睡眠呼吸暂停。三分之二的睡眠呼吸暂停为中度或重度(AHI≥15)。四分之一的呼吸事件由无血氧饱和度下降的觉醒定义。虽然大多数睡眠参数与年龄相仿的社区队列相似,但N3的平均百分比降低,仅占总睡眠时间的3.8%。
II型家庭睡眠测试(HST)显示该样本中睡眠呼吸暂停的患病率为97.8%,其中大部分是未被诊断的阻塞性睡眠呼吸暂停。大约三分之二的睡眠呼吸暂停为中度或重度。阻塞性睡眠呼吸暂停在严重主动脉瓣疾病患者中的如此高的影响值得对潜在的潜在机制和临床意义进行进一步研究。